The process by which amniotic membranes separated from the placenta bind to the cornea and are used as skin tissue regenerators

摘要

The present invention provides a process of extracting a functional skin substitute from amniotic membrane separated from placenta, combined with the use of mammalian cutin and its use as skin tissue regeneration agent, which is a process of generating artificial skin transplantation. In the laboratory, biotechnological expertise is used, for example, to culture mammalian cells, preferably human cells, and skin epidermal animals in sterile conditions.They are combined with a rich polystyrene mesh, obtained from the cells that make up the skin structure, plus the placental membrane, to produce two layers, which can be used in burn patients or skin injured patients; In addition, compared with the cost of existing methods such as skin transplantation (self transplantation or heterotopic transplantation), this technology greatly reduces the cost of treatment, resulting in rapid cell reorganization,The wound is repaired and re skinned by reorganizing the skin tissue and avoiding the formation of fibrous tissue due to muscle atrophy.